
|Podcasts|May 30, 2023
Health Equity Isn't a Theme, It's a Long-term Commitment
Advertisement
Wizdom Powell, PhD, MPH
Geetha Achanta, Scientific Director at OncLive
Tyrone Brewer, president of Janssen US Oncology
The 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO 2022) focused on health equity. Even though it’s not this year’s theme for ASCO, at Janssen, health equity remains our focus year-round. Consistent commitment is how we achieve lasting systemic change. We must work together as a health care system – including pharma, health care practitioners (HCPs), payors, and more – to tackle the inherent biases in our care system, break down barriers to access, and build trust.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5































